Authors


Kelly McCarty

Latest:

Opinion: Liquid Glass

Liquid glass? Isn’t glass solid?


Sandra Fyfe

Latest:

New Measles and Rubella Vaccine Found to be Safe and Effective

Mebella is another weapon in the global fight to eradicate these diseases.


Colleen Hall

Latest:

All Ages Need Education on Sunscreen

Data from one study showed younger women more likely to use sunscreen than older adults.


Erin Horvath, President, Distribution Services, AmerisourceBergen

Latest:

Relying on Your Distributor Through Natural Disasters

The critical role of distributors amid natural disasters, and strategies to protect and maintain the pharma supply chain




Pete Kreckel, RPh

Latest:

Here’s a Tip: More Money Is the Solution

In many industries, tipping is the norm. Pharmacists would just like to receive payment for services rendered.


Andrew J. Fratoni, PharmD and Kevin W. Chamberlin, PharmD

Latest:

Sunosi for Excessive Sleepiness in Adults with Narcolepsy or Obstructive Sleep Apnea

Solriamfetol (Sunosi, Jazz Pharmaceuticals) to treat excessive sleepiness in adult patients with narcolepsy or obstructive sleep apnea was approved on March 20, 2019.


Peter Wehrwein

Latest:

Q&A: PBM Legislation “Highly Likely” to Pass This Year

Following the Federal Trade Commission’s interim report on PBMs, legislators are galvanized to make change happen.



Gabrielle Ientile

Latest:

Cannabis Consulting: Are You Ready?

Most pharmacists are moderately to not-at-all comfortable answering patient questions about cannabis. That needs to change.



Elefterios Hamilakis, PharmD Candidate 2020

Latest:

Lumateprone Tosylate Approved for Schizophrenia

The FDA has approved lumateperone tosylate (Caplyta™, Intra-Cellular Therapies) for treatment of schizophrenia in adults.


Evan Williams, PharmD, MBA, BCPS, BCACP

Latest:

Literature Evaluation: More Than Just the Guidelines

Building literature evaluation skills is an essential teaching component during all stages of pharmacy education


Mallory Norman, BS, PharmD Candidate and Lisa M. Holle, PharmD, BCOP, FHOPA

Latest:

Entrectinib for ROS1-Positive NSCLC and NTRK-Positive Solid Tumors

In August 2019, the FDA approved entrectinib for treatment of adult patients with metastatic non-small cell lung cancer that is ROS1-positive.


Cedric White, PharmD candidate 2020, and Lisa M. Holle, PharmD, BCOP, FHOPA, FISOPP

Latest:

Darolutamide for Non-Metastatic Castration-Resistant Prostate Cancer

In July 2019, the FDA approved darolutamide (Nubeqa, Bayer) for men with prostate cancer that has not spread (ie, nonmetastatic) and no longer responds to medical or surgical treatment that lowers testosterone (ie androgen deprivation therapy).


Jennifer Akosa, PharmD/MBA Candidate 2020, and Lisa M. Holle, PharmD, BCOP, FHOPA, FISOPP

Latest:

Fam-trastuzumab Deruxtecan-nxki for HER2-Positive Unresectable or Metastatic Breast Cancer

Fam-trastuzumab deruxtecan-nxki (Enhertu, Daiichi Sankyo) is indicated for treating adults with unresectable or metastatic HER2-positive breast cancer who have received 2 or more prior anti-HER2–based regimens in the setting of metastasis.


Christina Graley, MD

Latest:

Evidence-Based Treatment for Pediatric Migraine Prevention

Migraine is one of the most common neurologic disorders in children and adolescents with a prevalence of 7.7%.


Christopher Oakley, MD

Latest:

Evidence-Based Treatment for Pediatric Migraine Prevention

Migraine is one of the most common neurologic disorders in children and adolescents with a prevalence of 7.7%.


Daniel S. Streetman, PharmD, MS, and Carrie W. Nemerovski, PharmD

Latest:

Drug Interaction Concerns for Potential COVID-19 Treatments

A close look at their potential to interact with other medications is required to limit the risk of adverse outcomes for patients.


Michael S. Awadalla, PharmD, BCGP

Latest:

The Need for Patient-Specific Medication Optimization Systems

Medication decision support tools focused on individual patients can help pharmacists effectively analyze risk of unintended harm, identify and assess potential interventions, and facilitate longitudinal care.


Liliana Armasaru, Benjamin Babayev, Emmanuel Damanakis, Heba Hezzini, Cassie Zeng, PharmD candidates

Latest:

Smell Disturbances in the Era of COVID-19

Some patients affected by COVID-19 may be concerned about hyposmia (reduced ability to smell) or anosmia (loss of smell) that they experience after contracting the virus.


Renata Block, MMS, PA-C

Latest:

Gut Health Has Impact on the Skin

The gut-brain-skin axis is more important to overall health than previously understood, and prebiotics and probiotics play a large role in the benefits.


Alex Biese

Latest:

Vitamin D Maintenance May Benefit Patients With Advanced Melanoma

Nearly 25% of people “have vitamin D blood levels that are too low or inadequate for bone and overall health,” according to the NIH.


Kyle Semmel, PharmD candidate

Latest:

Intranasal CGRP Antagonist Is Approved for the Treatment of Acute Migraines

Zavegepant joins other CGRP antagonists as an option for individuals experiencing migraine.


Brian Walker, RPh

Latest:

The Unyielding Grip of Fentanyl on America's Streets: A Pharmacist's Perspective

Independent pharmacists, health care providers, community leaders, and law enforcement must all work together to address the fentanyl epidemic.


Amy L. Kiskaddon, PharmD, MBA, BCPPS

Latest:

Medication Dosing in Pediatric Obesity Presents Complexities and Challenges

Careful thought and adjustments are required to avoid exceeding the maximum recommended amount.


Rim Elbeshbeshy, PharmD, BPS

Latest:

Review: Vaccine Guidelines for Older Adults

Vaccines are important for everyone, but they’re critical for adults older than 65 years.


Michael Berk, MD, PhD

Latest:

Mind-Body Resilience for Women: A Focus on Depression

Developing innovative solutions for women with depression, accounting for differences in gender and sex, are critically important


Don Sapatkin

Latest:

Are We Close To A Universal Flu Vaccine?

Seasonal influenza kills hundreds of thousands of people every year due to a constantly changing virus and highly inefficient vaccine production. A universal flu vaccine could deal with the first problem, and mRNA technology with the second.

© 2024 MJH Life Sciences

All rights reserved.